SJA-243

N/A

Report date: 2025/01/26 17:51:54
NME

Base Information

Drug NameSJA-243
Drug Alias Namedual CXCR4/ACKR3 inhibitor (University of Manchester/University of Hull/Rega Institute for Medical Research)dual CXCR4/CXCR7 inhibitor (University of Manchester/University of Hull/Rega Institute for Medical Research)SJA-243
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCXCR7 protein inhibitorsC-X-C motif chemokine receptor 4 antagonists
TargetsC-X-C chemokine receptor type 7C-X-C motif chemokine receptor 4
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of Manchester
China Registration ClassN/A

Develop Information

Active CompaniesRega Institute for Medical ResearchThe University Of ManchesterUniversity Of Hull
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A